Open original FDA record ↗Recall record
- FDA identifier
- Z-2500-2025
- Company in FDA record
- Visgeneer, Inc.
- FDA classification date
- Sep 2, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Due to products distributed without premarket clearance or approvals.
Source facts
- Action
- On 12/04/2023, the firm sent an email titled, "FDA notification about eBuricacid" to its distibutors informing them that Visgeneer has received a notice from FDA that the eBuricacid/Uritouch Blood uric acid monitors are not cleared to be marketed/distributed within the U.S. and is requesting that the products (kits and strips) be delisted from Amazon site as soon as possible. An additional email was sent to distributors on 06/23/2025 and 07/01/2025 as a follow up to the 12/04/2023 email - requesting for information on the quantities of monitors/kits and strips that were removed from Amazon, and instructing the distributor to destroy the stock of affected products on hand and noting that the strips are expired.
- Initiated
- 2023-10-04
- Root cause
- No Marketing Application
- Distribution
- Worldwide - U.S. Nationwide distribution in the states of CA and MI. The country of Canada.
- Recall number
- Z-2500-2025
- Recall status
- Open, Classified
- CDRH record ID
- 215231
- FDA classified
- 2025-09-02
- Recall event number
- 97328